USDA potentially finds an ASF vaccine

Published 2021년 10월 4일

Tridge summary

The USDA has developed a promising vaccine for African swine fever, a disease that has significantly impacted pig populations in China, Dominican Republic, and Haiti. The vaccine has shown to develop disease resistance in pigs within two weeks and in all animals within four weeks. The USDA is continuing to evaluate the vaccine's safety and efficacy in commercial settings, with plans to work with Navetko National Veterinary Joint Stock Company in Vietnam. The agency has also developed and patented five other experimental African swine fever vaccines and has issued seven licenses for research.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

The United States Department of Agriculture (USDA) has potentially found a vaccine to fight African swine fever, a disease that devastated pigs in China, was recently identified in the Dominican Republic, and even in Haiti. According to a posting on the agency's website, officials say the vaccine is "promising." According to the study, it develops disease resistance in one third of pigs within two weeks, and in all animals within four weeks. "This could play an important role in tackling the ongoing outbreak that threatens global pork supplies," said USDA study co-author Douglas Glade. US researchers will continue to determine the safety and efficacy of the vaccine in a commercial setting. They are now working with a commercial partner, Navetko National Veterinary Joint Stock Company, based in Vietnam. To date, the USDA has successfully developed and patented five experimental ASF vaccines and issued seven licenses to pharmaceutical companies to research them. ...

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.